Pasithea Therapeutics Corp.

KTTA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.51

-$0.01 (-2.62%)

At close: Sep 21, 2026, 4:00 PM ET

$0.51

$0 (+0.16%)

After-hours: Sep 21, 2026, 4:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	15.06K	n/a	n/a	n/a
Cost of Revenue	157.54K	157.54K	157.96K	n/a	n/a	n/a	162.26K	n/a	n/a	n/a	162.22K	n/a	n/a	n/a	4.14K	n/a	957	12.94K	17.28K	n/a	n/a	n/a
Gross Profit	-157.54K	-157.54K	-157.96K	n/a	n/a	n/a	-162.26K	n/a	n/a	n/a	-162.22K	n/a	n/a	n/a	-4.14K	n/a	-957	721	-2.21K	n/a	n/a	n/a
Operating Income	-5.71M	-4.88M	-10.26M	-3.11M	-3.81M	-3.68M	-3.26M	-3M	-3.95M	-4.04M	-5.15M	-3.79M	-3.83M	-3.21M	-4.04M	-3.86M	-2.61M	-2.08M	-1.96M	-1.27M	-727.95K	-549.61K
Interest Income	410.42K	450.34K	182.13K	43.4K	54.42K	47.25K	80.48K	75.08K	114.41K	153.22K	172.83K	131.74K	117.19K	n/a	102	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-5.27M	-2.87M	-10.11M	-3.04M	-3.72M	-3.56M	-3.18M	-3M	-3.87M	-3.86M	-5.03M	-3.61M	-3.6M	-3.27M	-4.05M	-4.19M	-2.19M	-1.29M	630.14K	-1.53M	-727.95K	-549.61K
Net Income	-5.27M	-2.87M	-10.11M	-3.04M	-3.72M	-3.56M	-3.18M	-3M	-3.87M	-3.86M	-5.05M	-3.61M	-3.76M	-3.54M	-5.12M	-4.59M	-2.66M	41.35K	630.14K	-1.53M	-727.95K	-549.61K
Selling & General & Admin	2.03B	1.93B	7.51M	1.75M	1.66M	1.95M	1.59M	1.42M	1.59M	2.29M	1.64M	2.16M	1.8M	2.12M	2.65M	2.58M	2.61M	2.08M	1.95M	1.27M	727.95K	549.61K
Research & Development	3.69B	2.94B	2.74M	1.36M	2.15M	1.73M	1.51M	1.58M	2.36M	1.75M	3.35M	1.62M	2.03M	1.1M	1.39M	1.28M	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	-5.71B	-4.87B	-157.96K	n/a	n/a	655	n/a	n/a	n/a	n/a	n/a	n/a	0	n/a	n/a	n/a	n/a	-12.94K	1.95M	1.27M	727.95K	549.61K
Operating Expenses	5.56M	4.72M	10.1M	3.11M	3.81M	3.68M	3.1M	3M	3.95M	4.04M	4.99M	3.79M	3.83M	3.21M	4.04M	3.86M	2.61M	2.07M	1.95M	1.27M	727.95K	549.61K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	6.39K	102	n/a	n/a	n/a	n/a	508	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	5.71M	4.88M	10.26M	3.11M	3.81M	3.68M	3.26M	3M	3.95M	4.04M	5.15M	3.79M	3.83M	3.21M	4.04M	3.86M	2.61M	2.08M	1.97M	1.27M	727.95K	549.61K
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	32.1M	7.03M	7.03M	7.44M	5.64M	1.1M	1.1M	1.04M	1.04M	1.04M	1.04M	1.26M	1.31M	1.3M	1.3M	1.33M	1.17M	1.15M	1.15M	660.42K	688.92K	688.92K
Shares Outstanding (Diluted)	32.1M	7.03M	7.03M	7.44M	5.64M	1.1M	1.1M	1.04M	1.04M	1.04M	1.04M	1.26M	1.31M	1.3M	1.3M	1.33M	1.17M	1.15M	1.15M	660.42K	688.92K	688.92K
EPS (Basic)	-0.16	-0.41	-0.89	-0.41	-0.66	-3.25	-2.90	-2.87	-3.71	-3.70	-4.85	-2.87	-2.88	-211.05	-3	-3.45	-2.27	-1.37	0.55	-2.31	-1.06	-0.80
EPS (Diluted)	-0.16	-0.41	-0.89	-0.41	-0.66	-3.25	-2.90	-2.87	-3.71	-3.70	-4.85	-2.87	-2.88	-211.05	-3	-3.45	-2.27	-1.37	0.55	-2.31	-1.06	-0.80
EBITDA	-5.56M	-4.72M	-10.1M	-2.93M	-3.65M	-3.52M	-3.02M	-2.84M	-3.78M	-3.88M	-4.87M	-3.63M	-3.67M	-3.05M	-4.05M	-4.17M	-2.19M	-1.29M	-1.96M	-1.27M	-727.95K	-549.61K
EBIT	-5.71M	-4.88M	-10.26M	-3.11M	-3.81M	-3.68M	-3.18M	-3M	-3.95M	-4.04M	-5.03M	-3.79M	-3.83M	-3.21M	-4.05M	-4.19M	-2.19M	-1.29M	-1.96M	-1.27M	-727.95K	-549.61K
Depreciation & Amortization	157.54K	157.54K	157.54K	181.59K	161.75K	161.71K	162.26K	162.26K	162.26K	162.26K	162.22K	162.26K	162.26K	161.72K	4.14K	16.67K	957	5.01K	345	1.27M	727.95K	549.61K